ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 244 filers reported holding ALKERMES PLC in Q1 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10 | -16.7% | 366 | -0.3% | 0.01% | -11.1% |
| Q2 2023 | $12 | +20.0% | 367 | -0.8% | 0.01% | 0.0% |
| Q1 2023 | $10 | -50.0% | 370 | -50.1% | 0.01% | +12.5% |
| Q4 2022 | $20 | -99.6% | 742 | +209.2% | 0.01% | +100.0% |
| Q3 2022 | $5,000 | – | 240 | +23900.0% | 0.00% | – |
| Q2 2022 | $0 | – | 1 | -75.0% | 0.00% | – |
| Q1 2022 | $0 | – | 4 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 4 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 14,040,000 | $313,513,000 | 35.43% |
| Krensavage Asset Management, LLC | 1,411,682 | $31,523,000 | 10.04% |
| Prosight Management, LP | 502,150 | $11,213,000 | 6.01% |
| Hardman Johnston Global Advisors LLC | 5,734,259 | $128,046,000 | 5.76% |
| 13D Management LLC | 415,055 | $9,268,000 | 4.85% |
| Ally Bridge Group (NY) LLC | 300,000 | $6,699,000 | 4.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 593,000 | $13,248,000 | 4.25% |
| GREAT POINT PARTNERS LLC | 507,500 | $11,332,000 | 2.73% |
| Tamarack Advisers, LP | 200,000 | $4,466,000 | 2.62% |
| Zebra Capital Management LLC | 22,134 | $494,000 | 1.88% |